Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2022
/
Article
/
Tab 5
/
Research Article
Enhanced Inhibitory Effect of DC-CIK Cells on Lung Adenocarcinoma via Anti-Tim-3 Antibody and Antiprogrammed Cell Death-1 Antibody and Possible Mechanism
Table 5
The cell phenotype of DC-CIK in different groups after blocking (
).
Group
CD4
+
CD8
+
Blank control
4.23 ± 0.79
93.54 ± 0.64
Tim-3 blockade
3.86 ± 1.20
93.59 ± 1.75
PD-1 blockade
4.15 ± 1.01
93.59 ± 0.83
Tim-3+PD-1 blockade
3.80 ± 1.15
94.22 ± 1.25